Pennsylvania patients faced severe withdrawal symptoms in autumn
Overdose clusters and severe withdrawal symptoms emerged in late 2024 following a drug supply shift in Pennsylvania. Clinicians identify the rapid withdrawal process as the primary source of complications.
- Field
- drugs and trials
- What they did
- Doctors noticed that medetomidine tablets appearing in pharmacies are causing severe withdrawal symptoms when stopped, due to changes in their composition.
- Why it matters
- This helps medical staff and patients understand why stopping the drug is now more dangerous than before and provides timely assistance.
#medetomidine#withdrawal#addiction#clinical trial


